Related references
Note: Only part of the references are listed.Atrial fibrillation, stroke, and quality of life
Jason S. Chinitz et al.
EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH (2012)
Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice
Josep M. Alegret et al.
BMC CARDIOVASCULAR DISORDERS (2012)
Atrial Fibrillation and Vascular DiseaseuA Bad Combination
Jonas Bjerring Olesen et al.
CLINICAL CARDIOLOGY (2012)
Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation
Luisa De Gennaro et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention
Irene Savelieva et al.
EUROPACE (2011)
Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats
Osamu Kume et al.
HEART RHYTHM (2011)
Inflammatory pathways underlying atrial fibrillation
Kai Friedrichs et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Host-pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: The role of CCL2 genetic variants
Carlos Alonso-Villaverde et al.
CYTOKINE (2010)
Role of inflammation and oxidative stress in atrial fibrillation
Jie Li et al.
HEART RHYTHM (2010)
Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk? A Mendelian Randomization of 47,000 Individuals From the General Population
Sarah C. W. Marott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Source of inflammatory markers in patients with atrial fibrillation
Ioan Liuba et al.
EUROPACE (2008)
Oxidative Stress and Inflammation in Atrial Fibrillation: Role in Pathogenesis and Potential as a Therapeutic Target
David R. Van Wagoner
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Genetically elevated C-reactive protein and ischemic vascular disease
Jeppe Zacho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of inflammation in initiation and perpetuation of atrial fibrillation - A systematic review of the published data
Tim T. Issac et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation
Josep M. Alegret et al.
EUROPACE (2007)
Monocyte chemoattractant protein-1 and atherosclerosis: Is there room for an additional biomarker?
Blai Coll et al.
CLINICA CHIMICA ACTA (2007)
Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction
Limei Zhou et al.
CIRCULATION RESEARCH (2006)
C-reactive protein in lone atrial fibrillation
Patrick T. Ellinor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Is atrial fibrillation an inflammatory disorder?
CJ Boos et al.
EUROPEAN HEART JOURNAL (2006)
C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion
O Wazni et al.
HEART (2005)
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the framingham heart study
DH McDermott et al.
CIRCULATION (2005)
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation
DSG Conway et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele
C Alonso-Villaverde et al.
CIRCULATION (2004)
Inflammation as a risk factor for atrial fibrillation
RJ Aviles et al.
CIRCULATION (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation
MK Chung et al.
CIRCULATION (2001)
Association study of schizophrenia with polymorphisms at six candidate genes
C Virgos et al.
SCHIZOPHRENIA RESEARCH (2001)
Classification system of atrial fibrillation
S Levy
CURRENT OPINION IN CARDIOLOGY (2000)
Share Paper
